in the 36 months since its inception , the national prostatic cancer project treatment subgroup has randomly assigned over 360 patients with progressive advanced prostatic cancer who were no longer responsive to endocrine manipulation to either one of four different clinical studies .
C0376358
prostatic cancer
C0033572
prostatic